Teijin Pharma

Tokyo, Japan· Est. 2020

Japanese pharmaceutical company developing treatments for respiratory, metabolic, and neurological disorders while providing integrated home healthcare solutions.

teijin-pharma.com

Is this your company? Claim your profile to update info and connect with investors.

Claim profile

Private Company

Funding information not available

AI Company Overview

Japanese pharmaceutical company developing treatments for respiratory, metabolic, and neurological disorders while providing integrated home healthcare solutions.

RespiratoryMetabolicNeuroscience

Technology Platform

Integrated 'Cure and Care' model combining pharmaceutical development with home healthcare services and digital health infrastructure like the VitalLink patient information system.

Opportunities

Growth opportunities include leveraging Japan's aging population to expand home healthcare services, advancing drug development in rare/intractable diseases, and scaling their integrated care model into other Asian markets.

Risk Factors

Key risks include reliance on the Japanese market, potential pricing pressure on pharmaceuticals and home medical equipment, and execution challenges in integrating drug development with service-based care models.

Competitive Landscape

Competes with other Japanese pharma companies (e.g., Takeda, Astellas) in drug development and with home medical equipment providers. Differentiates through its combined pharmaceutical and home healthcare service offering, creating a unique ecosystem for chronic disease management.

More companies in Japan →